2009年内分泌代谢疾病进展

被引：3

作者：

王绵

张力辉

苏胜偶

机构：

[1] 河北医科大学第二医院内分泌科

来源：

临床荟萃 | 2010年 / 25卷 / 07期

关键词：

糖尿病; 甲状腺疾病; 骨质疏松; 甲状旁腺疾病;

D O I：

暂无

中图分类号：

R58 [内分泌腺疾病及代谢病];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：553 / 555

页数：3

共 11 条

[1] 罗格列酮临床应用的研究进展 [J].

杨文英 .

中国新药杂志, 2009, (17) :1623-1624+1634

[2]

Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes: New results from the ADVANCE trial[J] . Zoungas,Sophia,de Galan,Bastiaan E,Ninomiya,Toshiharu,Grobbee,Diederick,Hamet,Pavel,Heller,Simon,MacMahon,Stephen,Marre,Michel,Neal,Bruce,Patel,Anushka,Woodward,Mark,Chalmers,John.Diabetes Care . 2009 (11)

[3] Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden [J].

Jonasson, J. M. ;

Ljung, R. ;

Talback, M. ;

Haglund, B. ;

Gudbjornsdottir, S. ;

Steineck, G. .

DIABETOLOGIA, 2009, 52 (09) :1745-1754

[4]

New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes[J] . Libby,Gillian,Donnelly,Louise A,Donnan,Peter T,Alessi,Dario R,Morris,Andrew D,Evans,Josie M M.Diabetes Care . 2009 (9)

[5] International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes [J].

Nathan, David M. ;

Balkau, Beverly ;

Bonora, Enzo ;

Borch-Johnsen, Knut ;

Buse, John B. ;

Colagiuri, Stephen ;

Davidson, Mayer B. ;

DeFronzo, Ralph ;

Genuth, Saul ;

Holman, Rury R. ;

Ji, Linong ;

Kirkman, Sue ;

Knowler, William C. ;

Schatz, Desmond ;

Shaw, Jonathan ;

Sobngwi, Eugene ;

Steffes, Michael ;

Vaccaro, Olga ;

Wareham, Nick ;

Zinman, Bernard ;

Kahn, Richard .

DIABETES CARE, 2009, 32 (07) :1327-1334

[6]

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group[J] . H. M. Colhoun.Diabetologia . 2009 (9)

[7] Intensive glucose control and macrovascular outcomes in type 2 diabetes [J].

Turnbull, F. M. ;

Abraira, C. ;

Anderson, R. J. ;

Byington, R. P. ;

Chalmers, J. P. ;

Duckworth, W. C. ;

Evans, G. W. ;

Gerstein, H. C. ;

Holman, R. R. ;

Moritz, T. E. ;

Neal, B. C. ;

Ninomiya, T. ;

Patel, A. A. ;

Paul, S. K. ;

Travert, F. ;

Woodward, M. .

DIABETOLOGIA, 2009, 52 (11) :2288-2298

[8] The influence of glucose-lowering therapies on cancer risk in type 2 diabetes [J].

Currie, C. J. ;

Poole, C. D. ;

Gale, E. A. M. .

DIABETOLOGIA, 2009, 52 (09) :1766-1777

[9]

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial[J] . Philip D Home,Stuart J Pocock,Henning Beck-Nielsen,Paula S Curtis,Ramon Gomis,Markolf Hanefeld,Nigel P Jones,Michel Komajda,John JV McMurray.The Lancet . 2009 (9681)

[10]

Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International Workshop[J] . John P. Bilezikian,Aliya A. Khan,John T. Potts.The Journal of Clinical Endocrinology & Metabolism . 2009 (2)

← 1 2 →